ZERO – The End of Prostate Cancer will host its second annual Health Equity Symposium 11 a.m. to 4:30 p.m. ET on Nov. 5. For more information or to register, visit zerocancer.org/hesymposium. The virtual event will address the status of prostate cancer disparities and what can be done to eliminate them.
“It is ZERO’s goal for everyone to have a fair and just opportunity to prevent, find, treat, and survive prostate cancer, regardless of race, sexual orientation, financial resources, physical abilities, or area of residence,” said Dr. Reggie Tucker-Seeley, ZERO’s vice president of health equity.
“Given the substantial disparity experienced by Black men where this group is more than 1.5 times more likely to be diagnosed with prostate cancer and more than twice as likely to die from the disease, a majority of the topics will focus on racial disparities,” he added.
The second annual Health Equity Symposium will focus on a wide range of topics, focused on conversations such as What is Health Equity?, Racial Disparities in Prostate Cancer, Place-Based Disparities in Prostate Cancer, Prostate Cancer and Cardiovascular Disease, Clinical Trial Participation and Black Men, and the Prostate Cancer in the Black Community Film Series.
Speakers include Tucker-Seeley; Dr. Kelvin A. Moses, associate professor of Urologic Surgery at Vanderbilt University Medical Center; Dr. Avirup Guha, director of Cardio-Oncology at Medical College of Georgia; Dr. Stanley Frencher, Jr., medical director of Surgical Outcomes and Quality at Martin Luther King, Jr. Community Hospital; Dr. Joseph Osborne, chief of Molecular Imaging and Therapeutics at Weill Cornell School of Medicine; Dr. Sanford Jeames, past-chair of ASCO Health Equity and Outcomes Committee; and Dr. Hala Borno, genitourinary oncologist at the University of California San Francisco and founder and CEO of Trial Library.
Film directors Landi Maduro, Reggie Hicks, and Terrance Anderson will also be presenting on their films related to health equity, focusing on health disparities within prostate cancer.
ZERO will also be presenting four awards during the Symposium: an Individual Award, an Organizational Award, a Lifetime Award, and an Advocacy Award.
ZERO — The End of Prostate Cancer is the leading national nonprofit with the mission to end prostate cancer and help all who are impacted. ZERO advances research, provides support, and creates solutions to achieve health equity to meet the most critical needs of the Black community.
